263 related articles for article (PubMed ID: 15645452)
1. Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cells.
Li Y; Mao Y; Rosal RV; Dinnen RD; Williams AC; Brandt-Rauf PW; Fine RL
Int J Cancer; 2005 May; 115(1):55-64. PubMed ID: 15645452
[TBL] [Abstract][Full Text] [Related]
2. Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143.
Li Y; Raffo AJ; Drew L; Mao Y; Tran A; Petrylak DP; Fine RL
Cancer Res; 2003 Apr; 63(7):1527-33. PubMed ID: 12670900
[TBL] [Abstract][Full Text] [Related]
3. C-Terminal p53 Palindromic Tetrapeptide Restores Full Apoptotic Function to Mutant p53 Cancer Cells In Vitro and In Vivo.
Fine RL; Mao Y; Dinnen R; Rosal RV; Raffo A; Hochfeld U; Senatus P; Bruce JN; Nichols G; Wang H; Li Y; Brandt-Rauf PW
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672645
[TBL] [Abstract][Full Text] [Related]
4. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
5. Correlation between hydrophobic properties and efficiency of carrier-mediated membrane transduction and apoptosis of a p53 C-terminal peptide.
Li Y; Rosal RV; Brandt-Rauf PW; Fine RL
Biochem Biophys Res Commun; 2002 Nov; 298(3):439-49. PubMed ID: 12413961
[TBL] [Abstract][Full Text] [Related]
6. Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide.
Senatus PB; Li Y; Mandigo C; Nichols G; Moise G; Mao Y; Brown MD; Anderson RC; Parsa AT; Brandt-Rauf PW; Bruce JN; Fine RL
Mol Cancer Ther; 2006 Jan; 5(1):20-8. PubMed ID: 16432159
[TBL] [Abstract][Full Text] [Related]
7. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.
Wang S; El-Deiry WS
Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15095-100. PubMed ID: 14645705
[TBL] [Abstract][Full Text] [Related]
8. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
Shankar S; Singh TR; Srivastava RK
Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092
[TBL] [Abstract][Full Text] [Related]
9. Wild-type p53 induced sensitization of mutant p53 TNF-resistant cells: role of caspase-8 and mitochondria.
Ameyar-Zazoua M; Larochette N; Dorothée G; Daugas E; Haddada H; Gouloumet V; Métivier D; Stancou R; Mami-Chouaib F; Kroemer G; Chouaib S
Cancer Gene Ther; 2002 Mar; 9(3):219-27. PubMed ID: 11896437
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
[TBL] [Abstract][Full Text] [Related]
11. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
[TBL] [Abstract][Full Text] [Related]
12. JNK/SAPK activity contributes to TRAIL-induced apoptosis.
Herr I; Wilhelm D; Meyer E; Jeremias I; Angel P; Debatin KM
Cell Death Differ; 1999 Feb; 6(2):130-5. PubMed ID: 10200559
[TBL] [Abstract][Full Text] [Related]
13. Frontline: Induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus.
Müller DB; Raftery MJ; Kather A; Giese T; Schönrich G
Eur J Immunol; 2004 Apr; 34(4):941-51. PubMed ID: 15048704
[TBL] [Abstract][Full Text] [Related]
14. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
15. Pediatric rhabdomyosarcoma cell lines are resistant to Fas-induced apoptosis and highly sensitive to TRAIL-induced apoptosis.
Petak I; Douglas L; Tillman DM; Vernes R; Houghton JA
Clin Cancer Res; 2000 Oct; 6(10):4119-27. PubMed ID: 11051265
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
17. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
Suliman A; Lam A; Datta R; Srivastava RK
Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
[TBL] [Abstract][Full Text] [Related]
18. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ
Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027
[TBL] [Abstract][Full Text] [Related]
19. Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha.
Imamura R; Konaka K; Matsumoto N; Hasegawa M; Fukui M; Mukaida N; Kinoshita T; Suda T
J Biol Chem; 2004 Nov; 279(45):46415-23. PubMed ID: 15337758
[TBL] [Abstract][Full Text] [Related]
20. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
Ozören N; El-Deiry WS
Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
